369 related articles for article (PubMed ID: 24905617)
1. Analysis of patients with stage IIIC endometrial cancer.
Turan T; Ureyen I; Duzguner I; Ozkaya E; Tasci T; Karalok A; Boran N; Kose MF; Tulunay G
Int J Gynecol Cancer; 2014 Jul; 24(6):1033-41. PubMed ID: 24905617
[TBL] [Abstract][Full Text] [Related]
2. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
3. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.
Alay I; Turan T; Ureyen I; Karalok A; Tasci T; Ozfuttu A; Kose MF; Tulunay G
Pathol Oncol Res; 2015 Jul; 21(3):803-10. PubMed ID: 25564000
[TBL] [Abstract][Full Text] [Related]
4. Survival advantage of lymphadenectomy in endometrial cancer.
Eggemann H; Ignatov T; Kaiser K; Burger E; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2016 May; 142(5):1051-60. PubMed ID: 26746654
[TBL] [Abstract][Full Text] [Related]
5. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
Fehm T; Banys M; Rack B; Janni W; Marth C; Blassl C; Hartkopf A; Trope C; Kimmig R; Krawczyk N; Wallwiener D; Wimberger P; Kasimir-Bauer S
Int J Gynecol Cancer; 2013 Jun; 23(5):839-45. PubMed ID: 23694981
[TBL] [Abstract][Full Text] [Related]
6. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging.
Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA
Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247
[TBL] [Abstract][Full Text] [Related]
7. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
[TBL] [Abstract][Full Text] [Related]
8. Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.
McNally L; Teng NN; Kapp DS; Karam A
Int J Gynecol Cancer; 2015 May; 25(4):607-15. PubMed ID: 25756404
[TBL] [Abstract][Full Text] [Related]
9. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival.
Bristow RE; Zahurak ML; Alexander CJ; Zellars RC; Montz FJ
Int J Gynecol Cancer; 2003; 13(5):664-72. PubMed ID: 14675352
[TBL] [Abstract][Full Text] [Related]
10. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
Kikuchi A; Yanase T; Sasagawa M; Honma S
J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906
[TBL] [Abstract][Full Text] [Related]
11. The effect of introducing pelvic lymphadenectomy on survival and recurrence rates in Danish endometrial cancer patients at high risk: a Danish Gynecological Cancer Group study.
Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M
Int J Gynecol Cancer; 2019 Jan; 29(1):68-76. PubMed ID: 30640686
[TBL] [Abstract][Full Text] [Related]
12. The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients.
Fang C; Zhang Y; Zhao L; Chen X; Xia L; Zhang P
BMC Cancer; 2020 Jul; 20(1):654. PubMed ID: 32660444
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
[TBL] [Abstract][Full Text] [Related]
14. The incidence and clinical significance of the micrometastases in the sentinel lymph nodes during surgical staging for early endometrial cancer.
Ferraioli D; Chopin N; Beurrier F; Carrabin N; Buenerd A; Mathevet P
Int J Gynecol Cancer; 2015 May; 25(4):673-80. PubMed ID: 25902281
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.
Gadducci A; Cosio S; Zola P; Sostegni B; Fuso L; Sartori E
Int J Gynecol Cancer; 2013 Mar; 23(3):461-8. PubMed ID: 23370604
[TBL] [Abstract][Full Text] [Related]
17. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study.
Coronado PJ; Fasero M; Baquedano L; Martinez-Maestre MA; Casado A; Vidart JA; Herraiz MA
Int J Gynecol Cancer; 2014 May; 24(4):703-12. PubMed ID: 24651627
[TBL] [Abstract][Full Text] [Related]
18. Survival impact of lymphadenectomy stratified by nodal metastatic probability in endometrial cancer.
Koskas M; Fournier M; Luton D; Darai E; Rouzier R
Ann Surg Oncol; 2014 Jul; 21(7):2376-82. PubMed ID: 24590435
[TBL] [Abstract][Full Text] [Related]
19. Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations.
Gallotta V; Fanfani F; Fagotti A; Chiantera V; Legge F; Gueli Alletti S; Nero C; Margariti AP; Papa V; Alfieri S; Ciccarone F; Scambia G; Ferrandina G
Ann Surg Oncol; 2014 Jul; 21(7):2369-75. PubMed ID: 24558070
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer.
Risum S; Loft A; Engelholm SA; Høgdall E; Berthelsen AK; Nedergaard L; Lundvall L; Høgdall C
Int J Gynecol Cancer; 2012 Sep; 22(7):1163-9. PubMed ID: 22810969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]